How to Cure a Week-Long Migraine That Won’t Break

A migraine that has been grinding for a full week has almost certainly crossed the threshold doctors call status migrainosus, defined as a migraine attack lasting more than 72 hours with pain that stays moderate to severe. At that point, the brain’s pain-processing system has shifted into a self-sustaining loop that standard over-the-counter painkillers are unlikely to interrupt. Breaking it usually requires medical intervention, often in layers, and the longer it runs, the harder it becomes to stop. Understanding why the attack is stuck and what treatments exist at each level of escalation can help you work with your doctor to end it and keep it from happening again.

Why a Week-Long Migraine Gets Stuck

The reason a migraine becomes self-perpetuating has a lot to do with how pain signals change over time. When a migraine persists for days, the neurons in your brainstem and upper spinal cord become increasingly excitable. Stimuli that wouldn’t normally register as painful, like light touch on the scalp or moving your head, start to hurt. This phenomenon, called allodynia, has been observed in roughly 60% of migraine patients and up to 90% of those with chronic migraine.¹ Once this sensitization takes hold, each hour of unrelieved pain makes the nervous system more resistant to treatment. Think of it like a feedback loop where the pain itself is making the volume knob harder to turn down.

Another major contributor is medication overuse. If you’ve been taking triptans, NSAIDs, or combination analgesics on most days to cope with the unrelenting headache, those same drugs may be fueling the cycle. Medication overuse headache is now understood as a worsening of a pre-existing headache caused by frequent use of the very medications meant to abort it. All common abortive headache drugs can trigger it when used regularly enough.² The tricky part is distinguishing an attack that won’t stop on its own from one that keeps restarting because of rebound. Your doctor needs to sort this out before the right treatment plan can take shape.

When to Seek Emergency Care

Not every prolonged migraine needs the emergency department, but certain warning signs demand urgent evaluation because they could signal something other than migraine. Red flags include sudden onset of severe pain unlike any headache you’ve had before, focal neurological symptoms like weakness on one side or trouble speaking, seizures, high fever, and headache triggered or worsened by physical activity or straining.³ A headache that changes character abruptly after years of familiar migraines also warrants investigation. Clinicians use structured screening tools to catch secondary headaches disguised as migraine, and a week-long headache that doesn’t respond to your usual treatments is itself a reason to be seen.⁴

Even without red flags, going to the ER or an urgent headache clinic after several days of unbroken pain is reasonable. People with status migrainosus have higher rates of emergency visits and hospitalizations, and waiting too long can make the attack harder to treat and increase the risk of the migraine becoming chronic. Early treatment matters.

What Happens in the Emergency Department

Emergency treatment of a stubborn migraine focuses on combination intravenous therapy using several non-opioid medications from different drug classes. The goal is to hit the pain through multiple pathways at once rather than relying on a single drug.⁵ Opioids are deliberately avoided because they tend to worsen migraine over time and increase the chance of the headache bouncing back after discharge.

The most evidence-backed first-line options in the ER include intravenous metoclopramide, prochlorperazine, and subcutaneous sumatriptan. The American Headache Society has recommended all three as drugs that should be offered to eligible adults presenting with acute migraine.⁶ Metoclopramide and prochlorperazine are dopamine receptor antagonists, a class that carries strong evidence for migraine relief. They also help with the nausea that often makes a prolonged migraine unbearable. Other commonly used agents in the ER cocktail include IV magnesium sulfate, IV ketorolac or other NSAIDs, anticonvulsants, and serotonergic agents.⁷

The Surprisingly Weak Case for IV Fluids Alone

You’ll almost always get an IV bag of saline in the ER, and dehydration does make migraine worse, so this feels intuitive. But the evidence that IV fluids themselves break the headache is surprisingly thin. A post hoc analysis of clinical trial data found that patients who received IV fluids actually improved slightly less on a 10-point pain scale than those who didn’t, and rates of sustained headache freedom were no different between the two groups.⁸ A more recent trial did find that adding IV saline to NSAID treatment modestly reduced the need for rescue medication and shortened the ER stay by about 20 minutes, though the difference in pain reduction between groups wasn’t statistically significant.⁹ The upshot: IV fluids are a sensible part of care, especially since many people with a week-long migraine haven’t been eating or drinking well, but they’re not the cure. The drugs riding alongside the saline are doing the heavy lifting.

Steroid Rescue

Corticosteroids are one of the most important tools for preventing a migraine from roaring back after initial ER treatment. Dexamethasone is the most commonly used steroid for this purpose, typically given as a single intravenous dose in the range of 10 mg. It decreases the frequency of moderate or severe headache returning within 72 hours of discharge.¹⁰ Multiple randomized trials and meta-analyses have confirmed that a single dose of dexamethasone prevents recurrence in a meaningful proportion of patients, and the side-effect profile is mild.¹¹ For a week-long migraine, your doctor may also prescribe a short tapering course of oral steroids to take at home after discharge. This bridge is meant to quiet the inflammatory and sensitization processes long enough for the nervous system to reset.

Steroids don’t work like a painkiller. They address the underlying neurogenic inflammation driving the attack. For someone whose migraine has been raging for days, that anti-inflammatory action tackles a different layer of the problem than the dopamine antagonists or triptans do. That’s why they’re often given together.

Nerve Blocks

Greater occipital nerve blocks are an underused but increasingly recognized intervention for migraines that resist standard medications. The procedure involves injecting a local anesthetic, often bupivacaine or lidocaine, around the greater occipital nerve at the back of the skull. It takes minutes, requires no sedation, and the results can be dramatic. In one randomized controlled trial, about 95% of patients who received a nerve block alongside standard care achieved at least a 50% reduction in pain within two hours, compared to about 48% of those getting standard care alone.¹²

Even in patients who had already failed standard ER treatment with metoclopramide, a bilateral occipital nerve block achieved headache freedom at 30 minutes in about a third of cases versus none in the sham group.¹³ The block’s effect at 30 and 45 minutes has also been shown to outperform both placebo and dexketoprofen.¹⁴ If you’re in the ER with a week-long migraine and the IV cocktail isn’t getting you there, asking about a nerve block is worth doing. Not every ER physician performs them routinely, but a headache specialist or neurologist on call often can.

Dihydroergotamine for Refractory Attacks

When triptans haven’t worked and the standard ER approach falls short, intravenous dihydroergotamine (DHE) is often the next step. DHE is an older drug, but it remains clinically useful for migraine attacks that don’t respond to triptans and for patients with a high overall migraine burden.¹⁵ The classic “Raskin protocol” involves repeated IV DHE doses over several days in a hospital setting, often combined with antiemetics, because DHE can cause significant nausea. For someone whose migraine has already lasted a week, a multi-day DHE infusion protocol is one of the most established interventions available, though it requires admission.

Lidocaine and Ketamine Infusions

For the truly refractory cases where even DHE doesn’t break through, some headache centers offer continuous intravenous lidocaine or ketamine infusions. These are aggressive inpatient treatments reserved for patients who have exhausted other options.¹⁶ In a retrospective study of patients treated with lidocaine infusions, about half achieved at least a 50% reduction in pain, typically after four to five days of infusion, and roughly a third became pain-free over about six days. Ketamine infusions showed a lower response rate, with about a third achieving 50% pain reduction and about 16% reaching pain freedom.¹⁷

These numbers reflect how difficult refractory migraine can be to treat. The patients in these studies had already failed multiple other therapies. Lidocaine and ketamine infusions require cardiac monitoring and careful dose titration, so they happen in specialized headache units, not typical ERs. If your headache specialist is considering this level of treatment, it signals that your case is genuinely complex, and it’s still a reasonable path forward.

Newer Medications Worth Discussing With Your Doctor

Two newer drug classes have expanded the options for acute migraine treatment, especially for people who can’t tolerate triptans or have cardiovascular conditions that make triptans unsafe. Gepants are small-molecule drugs that block the CGRP receptor, a key player in migraine pain signaling. They are slightly less effective than triptans on average but have fewer side effects and don’t constrict blood vessels. Ditans are serotonin receptor agonists that also avoid vasoconstriction, making them another option for people with heart disease or stroke risk.¹⁸

For a week-long migraine specifically, gepants are interesting because some of them (like rimegepant and atogepant) can be used for both acute treatment and prevention, potentially serving double duty as you transition from breaking the current attack to stopping the next one. A neurologist or headache specialist is the right person to discuss whether one of these newer agents fits your situation, particularly if you’ve been cycling through triptans and NSAIDs without success.

Neuromodulation Devices

Several FDA-cleared handheld devices use electrical or magnetic stimulation to treat migraine without drugs. A meta-analysis of randomized trials found that non-invasive neuromodulation roughly doubles the chance of being pain-free within two hours compared to sham stimulation.¹⁹ The International Headache Society has issued weak recommendations for several specific devices, including gammaCore (a vagus nerve stimulator), Cefaly (a supraorbital nerve stimulator), Nerivio (a remote electrical neurostimulation device), and others for both acute and preventive use.²⁰

“Weak recommendation” sounds discouraging, but in clinical guideline language it means the evidence supports use while acknowledging the studies are smaller than what you’d see for major pharmaceuticals. In the PRESTO trial, vagus nerve stimulation was more effective than sham for pain freedom at 30 and 60 minutes.²¹ These devices won’t replace IV medications for a severe week-long attack, but they can be part of a layered approach, especially for someone who has maxed out on medication doses or wants to reduce drug intake going forward. They’re also useful during the recovery phase after the worst of the attack has been broken, when you want to avoid taking another dose of a triptan or NSAID.

The Medication Overuse Trap

This deserves its own discussion because it’s the single most common reason migraines become chronic and treatment-resistant. If you’ve been taking acute headache medications on 10 or more days per month for triptans, or 15 or more days for simple analgesics, you’re in the zone where medication overuse headache becomes likely. The cruel irony is that the drugs keeping the pain at bay are also preventing your brain from recovering between attacks.

Reducing and eventually stopping the overused medication is the standard treatment, but experts disagree on the best way to do it. Some advocate abrupt withdrawal with a bridge therapy like steroids or DHE, while others prefer gradual tapering. Among patients who successfully discontinue the overused drug, about half to 70% revert to an episodic headache pattern.² That’s a meaningful success rate, but it also means a substantial minority don’t improve with withdrawal alone, underscoring the need for preventive medication to be started alongside the detox.

Building a Plan to Prevent It From Happening Again

Breaking a week-long migraine is only half the battle. People who experience status migrainosus have higher rates of progression to chronic migraine, and clinicians increasingly emphasize that developing a plan for both prevention and early treatment of prolonged attacks is essential. Your doctor should help you identify a preventive medication strategy, whether that’s a daily oral preventive, a monthly CGRP monoclonal antibody injection, or a combination. Equally important is having a clear escalation plan for future attacks: what to take at onset, what to switch to if that fails after a set number of hours, and at what point to seek infusion therapy or an ER visit rather than continuing to self-treat at home.

Lifestyle factors also feed into the autonomic nervous system instability that makes migraines more likely to spiral. Poor sleep, irregular meals, bright lights, and hormonal shifts all alter autonomic function in ways that can lower the threshold for a prolonged attack.²² None of this is to say lifestyle changes cure migraine, but stabilizing sleep schedules and eating patterns reduces the number of triggers stacking on top of each other.

Special Situations

Prolonged migraine during pregnancy requires a different approach because many standard treatments are off the table. Nonpharmacological strategies, including ice, rest, hydration, and relaxation techniques, are always the first line. When medication is necessary, acetaminophen remains the safest acute option during pregnancy and breastfeeding, and sumatriptan is considered an acceptable treatment for breakthrough attacks in both settings.²³ Most other migraine drugs, including NSAIDs after the first trimester, ergots, and many preventives, carry safety concerns that need case-by-case evaluation with an obstetrician and neurologist working together.

Children and adolescents with intractable migraine face a different set of challenges. There’s no unified definition of intractable migraine in this age group, and treatment data is limited, with most protocols adapted from adult studies or based on expert consensus rather than pediatric trials.²⁴ If your child has a migraine lasting days, a pediatric neurologist should be involved. The general principles of combination therapy and avoiding opioids still apply, but doses and drug choices differ.

The Financial Reality of Prolonged Migraine Care

One barrier to appropriate treatment is the cost. An average ER visit for migraine in the United States has been estimated at roughly $775, and if the attack requires inpatient admission, the average cost climbs above $7,300.²⁵ These figures are from 2010 data and would be higher today. That financial pressure sometimes pushes people to keep trying to manage at home long past the point where home management is working. Having a written action plan from your headache specialist that includes criteria for when to escalate can help you make that decision sooner, which paradoxically can reduce total costs by preventing a brief ER visit from turning into a multi-day admission. Insurance pre-authorization for infusion centers and outpatient headache clinics is another practical step worth pursuing before you find yourself in crisis.